TherapeuticsMD, Inc.
TXMDNasdaqCIK 25743HealthcareFiscal year ends Dec 31
Reports and events: 392 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2013-05-1609:52 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001387131-13-001906 |
| 2013-05-1006:04 ET | 10-Q | Quarterly reportPeriod 2013-03-31 | 0001387131-13-001675 |
| 2013-05-0817:27 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001387131-13-001637 |
| 2013-05-0317:06 ET | SC 13D | Ownership report, active investor | 0001387131-13-001537 |
| 2013-05-0317:03 ET | SC 13D | Ownership report, active investor | 0001387131-13-001536 |
| 2013-05-0215:40 ET | SC 13D | Ownership report, active investor | 0001387131-13-001510 |
| 2013-04-2309:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001387131-13-001425 |
| 2013-03-1517:20 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-13-110300 |
| 2013-03-1216:43 ET | 10-K | Annual reportPeriod 2012-12-31 | 0001387131-13-000737 |
| 2013-03-0717:27 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-13-096310 |
| 2013-02-0617:07 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001387131-13-000292 |
| 2013-02-0412:36 ET | SC 13D | Ownership report, active investor | 0001387131-13-000263 |
| 2013-02-0412:34 ET | SC 13D | Ownership report, active investor | 0001387131-13-000261 |
| 2013-01-2507:14 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001387131-13-000163 |
| 2012-12-0415:34 ET | SC 13D | Ownership report, active investor | 0001387131-12-003943 |
| 2012-12-0415:33 ET | SC 13D | Ownership report, active investor | 0001387131-12-003941 |
| 2012-11-2715:42 ET | S-1 | Registration statement | 0001387131-12-003907 |
| 2012-11-1313:53 ET | 10-Q | Quarterly reportPeriod 2012-09-30 | 0001387131-12-003625 |
| 2012-10-0217:04 ET | SC 13D | Ownership report, active investor | 0001387131-12-003122 |
| 2012-10-0217:02 ET | SC 13D | Ownership report, active investor | 0001387131-12-003120 |
| 2012-10-0217:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001387131-12-003118 |
| 2012-08-0917:13 ET | 10-Q | Quarterly reportPeriod 2012-06-30 | 0001387131-12-002558 |
| 2012-08-0714:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-12-002460 |
| 2012-07-2017:34 ET | SC 13D | Ownership report, active investor | 0001387131-12-002230 |
| 2012-07-2017:31 ET | SC 13D | Ownership report, active investor | 0001387131-12-002228 |
| 2012-07-1017:22 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-12-002109 |
| 2012-07-0216:32 ET | SC 13D | Ownership report, active investor | 0001387131-12-002035 |
| 2012-07-0216:30 ET | SC 13D | Ownership report, active investor | 0001387131-12-002032 |
| 2012-06-2113:56 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001387131-12-001975 |
| 2012-06-2112:55 ET | SC 13D | Ownership report, active investor | 0001387131-12-001973 |
| 2012-06-2112:45 ET | SC 13D | Ownership report, active investor | 0001387131-12-001971 |
| 2012-06-2112:43 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001387131-12-001969 |
| 2012-05-1714:11 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001387131-12-001681 |
| 2012-05-1116:58 ET | 10-Q | Quarterly reportPeriod 2012-03-31 | 0001387131-12-001510 |
| 2012-04-1716:41 ET | SC 13D | Ownership report, active investor | 0001387131-12-001213 |
| 2012-04-1716:40 ET | SC 13D | Ownership report, active investor | 0001387131-12-001211 |
| 2012-04-1716:39 ET | SC 13D | Ownership report, active investor | 0001387131-12-001209 |
| 2012-03-2717:27 ET | 10-K | Annual reportPeriod 2011-12-31 | 0001387131-12-000862 |
| 2012-03-0213:55 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001387131-12-000556 |
| 2012-02-2817:23 ET | SC 13D | Ownership report, active investor | 0001387131-12-000519 |
| 2012-02-2817:18 ET | SC 13D | Ownership report, active investor | 0001387131-12-000516 |
| 2012-02-2417:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001387131-12-000490 |
| 2012-02-0315:26 ET | 8-K/A | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001387131-12-000194 |
| 2012-02-0210:40 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001387131-12-000184 |
| 2012-01-2517:11 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001387131-12-000095 |
| 2011-12-0914:31 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001387131-11-002761 |
| 2011-12-0813:51 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001387131-11-002748 |
| 2011-11-2311:48 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001387131-11-002712 |
| 2011-11-2213:29 ET | 8-K/A | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001387131-11-002684 |
| 2011-11-0717:27 ET | 10-Q | Quarterly reportPeriod 2011-09-30 | 0001387131-11-002429 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 19:24 ET. Listed shows no prices and gives no investment advice.